Independent CGT Manufacturers Join Forces to Give Developers one Front Door to Global CGT Manufacturing

Alliance of CGT Manufacturing Partners (ACGMP) founding members aim to help cell and gene therapy developers find manufacturing partners across regions and modalities, with a shared focus on global patient access

PHOENIX, Arizona, [October 5, 2026] – Cell and gene therapies may now be moving faster than the manufacturing networks built to deliver it. The Alliance of CGT Manufacturing Partners (ACGMP) is launching a global network of independent, specialist contract development and manufacturing organizations (CDMOs) to help close that gap. The alliance aims to give developers a coordinated, no-cost way to identify partners with the technical capabilities and regional presence their programs require.

ACGMP will launch at the Cell & Gene Meeting on the Mesa in Phoenix. Its founding members are convening an invitation-only gathering for developers on Tuesday, October 6. Patient advocate Brad Watts will open the gathering by speaking about global access to therapies, the theme of the alliance, followed by a discussion of manufacturing challenges. The gathering will also support the Emily Whitehead Foundation.

The alliance is intended to support developers from early process development through scale-up and commercial manufacturing. Its members’ capabilities span autologous and allogeneic cell therapies, gene therapies, and include viral vectors, RNA, lipid nanoparticles, plasmid DNA and apheresis starting materials. ACGMP also plans to develop shared quality and technology transfer tools, including quality agreements, pre-audits and site visits, and to create opportunities for member technical and quality teams to work together.

“Great therapies should not stall at a border,” said Bev Menner, CEO, Cell Therapies Pty, an ACGMP founding member.

The founding member organizations are Cell Therapies (Melbourne), eXmoor Pharma (UK), Nucelion Therapeutics (Hyderabad), Siam Bioscience (Bangkok), SCTbio (Prague), Teijin REGENET (Tokyo) and Xellera (Hong Kong). ACGMP is seeking additional members, including in the United States and China.

About the Alliance of CGT Manufacturing Partners

The Alliance of CGT Manufacturing Partners (ACGMP) brings together independent, specialist CDMOs to connect cell and gene therapy developers with manufacturing expertise across regions and modalities. Its founding members work across cell therapies, viral vectors, plasmid DNA, RNA and related starting materials. The alliance plans to support multi-region programs through member collaboration on quality and technology transfer. Developers can contact the alliance at info@acgmp.global. There is no cost to developers. www.acgmp.global

For media enquiries, please contact:

Suzanna Muggleton, IB Comms
suzanna@ibcomms.agency